Check Point Software Technologies Ltd. | 2,350.00 / -7.65% |
Date/Time | 02/22 / 00:00 |
Chg. / Chg.(%) | -194.58 / -7.65% |
Bid | 2,698.41 |
Ask | 2,698.41 |
Open | 2,390.00 |
Previous Close | 2,544.58 |
High | 2,390.00 |
Low | 2,350.00 |
Volume [MXN] | - |
Volume [Units] | 156 |
Price fixings | |
ISIN | IL0010824113 |
Security | CHKP/N |
Exchange | Mexico |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
NASDAQ | 114.2500 | ![]() |
1,649,300 |
IEX | 114.32 | ![]() |
135,035 |
Cboe US | 114.31 | ![]() |
80,956 |
Stuttgart | 95.080 | ![]() |
9,002 |
TradeGate | 95.800 | ![]() |
1,156 |
Vienna Globa.. | 93.71 | ![]() |
280 |
Frankfurt | 93.4700 | ![]() |
224 |
gettex | 95.530 | ![]() |
65 |
München | 93.07 | ![]() |
14 |
Hamburg | 93.41 | ![]() |
10 |
Hannover | 92.29 | ![]() |
0 |
Berlin | 95.33 | ![]() |
0 |
Düsseldorf | 95.74 | ![]() |
0 |
Lang & Schwa.. | 96.420 | ![]() |
|
London Inter.. | 109.79 | 20 | |
Mexico | 2,350.00 | ![]() |
156 |
News
- ALX Oncology and Tallac Therapeutics Announce Collaboration on Novel Class of Cancer Immunotherapeutics
03/04/2021 / 22:05 - GlobeNewswire - Checkpoint Therapeutics to Participate in H.C. Wainwright Global Life Sciences Virtual Conference
03/04/2021 / 14:00 - GlobeNewswire - Replimune to Present at Three Upcoming Investor Conferences
03/04/2021 / 14:00 - GlobeNewswire - BioXcel Therapeutics to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call and Webcast
03/04/2021 / 13:00 - GlobeNewswire - Tempest Therapeutics Announces Clinical Collaboration with Roche to Advance TPST-1120 into a Randomized Combination Study in First-line Hepatocellular Carcinoma
03/03/2021 / 14:00 - GlobeNewswire